share_log

三葉草生物-B：董事會會議日期

CLOVER BIO-B: DATE OF BOARD MEETING

HKEX ·  Aug 15 16:31

Summary by Moomoo AI

三葉草生物製藥有限公司（「三叶草生物-B」）將於2024年8月27日（星期二）舉行董事會會議，目的是考慮及批准截至2024年6月30日止六個月的中期業績報告及其發佈。會議同時將討論是否建議派發中期股息。該公司由梁朋博士擔任董事長，並於2024年8月15日在中國上海發出此公告。董事會成員包括執行董事梁朋博士及梁果先生，非執行董事王曉東博士、Donna Marie AMBROSINO博士、Ralf Leo CLEMENS博士，以及獨立非執行董事吳曉濱博士、廖想先生、Jeffrey FARROW先生及Thomas LEGGETT先生。
三葉草生物製藥有限公司（「三叶草生物-B」）將於2024年8月27日（星期二）舉行董事會會議，目的是考慮及批准截至2024年6月30日止六個月的中期業績報告及其發佈。會議同時將討論是否建議派發中期股息。該公司由梁朋博士擔任董事長，並於2024年8月15日在中國上海發出此公告。董事會成員包括執行董事梁朋博士及梁果先生，非執行董事王曉東博士、Donna Marie AMBROSINO博士、Ralf Leo CLEMENS博士，以及獨立非執行董事吳曉濱博士、廖想先生、Jeffrey FARROW先生及Thomas LEGGETT先生。
Three Clover Biopharmaceutical Co., Ltd. ("Three Clover Bio-B") will hold a board meeting on Tuesday, August 27, 2024, to consider and approve the interim performance report for the six months ending June 30, 2024, and its release. The meeting will also discuss whether to recommend the distribution of interim dividends. The company is chaired by Dr. Liang Peng and issued this announcement in Shanghai, China on August 15, 2024. Board members include executive directors Dr. Liang Peng and Mr. Liang Guo, non-executive directors Dr. Wang Xiaodong, Donna Marie Ambrosino, and Ralf Leo Clemens, as well as independent non-executive directors Dr. Wu Xiaobin, Mr. Liao Xiang, Mr. Jeffrey Farrow, and Mr. Thomas Leggett.
Three Clover Biopharmaceutical Co., Ltd. ("Three Clover Bio-B") will hold a board meeting on Tuesday, August 27, 2024, to consider and approve the interim performance report for the six months ending June 30, 2024, and its release. The meeting will also discuss whether to recommend the distribution of interim dividends. The company is chaired by Dr. Liang Peng and issued this announcement in Shanghai, China on August 15, 2024. Board members include executive directors Dr. Liang Peng and Mr. Liang Guo, non-executive directors Dr. Wang Xiaodong, Donna Marie Ambrosino, and Ralf Leo Clemens, as well as independent non-executive directors Dr. Wu Xiaobin, Mr. Liao Xiang, Mr. Jeffrey Farrow, and Mr. Thomas Leggett.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated